U.S. Physical Therapy (NYSE:USPH) Price Target Raised to $95.00

U.S. Physical Therapy (NYSE:USPH) had its target price upped by JPMorgan Chase & Co. from $90.00 to $95.00 in a report published on Friday morning,Benzinga reports. They currently have an overweight rating on the stock.

A number of other analysts have also commented on USPH. Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. Zacks Research upgraded shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Barrington Research raised their target price on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $98.00 target price on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th. Finally, Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 19th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, U.S. Physical Therapy has an average rating of “Moderate Buy” and an average price target of $98.25.

U.S. Physical Therapy Trading Down 0.1%

U.S. Physical Therapy stock opened at $78.64 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.27 and a quick ratio of 1.27. U.S. Physical Therapy has a one year low of $58.19 and a one year high of $93.50. The stock has a market capitalization of $1.17 billion, a PE ratio of 462.64, a price-to-earnings-growth ratio of 2.17 and a beta of 1.13. The business’s fifty day moving average is $77.06 and its 200 day moving average is $73.08.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.06). The business had revenue of $214.06 million during the quarter, compared to the consensus estimate of $211.36 million. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%.U.S. Physical Therapy’s quarterly revenue was up 8.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.81 earnings per share. On average, sell-side analysts predict that U.S. Physical Therapy will post 2.95 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Friday, August 21st were paid a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date was Friday, August 21st. U.S. Physical Therapy’s payout ratio is currently 1,082.35%.

Hedge Funds Weigh In On U.S. Physical Therapy

Several institutional investors have recently made changes to their positions in USPH. Hantz Financial Services Inc. increased its stake in U.S. Physical Therapy by 56.4% during the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock worth $29,000 after acquiring an additional 132 shares during the last quarter. Huntington National Bank lifted its stake in shares of U.S. Physical Therapy by 15.4% in the 4th quarter. Huntington National Bank now owns 1,052 shares of the company’s stock valued at $82,000 after purchasing an additional 140 shares during the last quarter. Osaic Holdings Inc. lifted its stake in shares of U.S. Physical Therapy by 1.6% in the 2nd quarter. Osaic Holdings Inc. now owns 10,447 shares of the company’s stock valued at $817,000 after purchasing an additional 166 shares during the last quarter. Snowden Capital Advisors LLC boosted its holdings in shares of U.S. Physical Therapy by 3.6% in the 2nd quarter. Snowden Capital Advisors LLC now owns 5,600 shares of the company’s stock worth $438,000 after purchasing an additional 195 shares during the period. Finally, Janney Montgomery Scott LLC boosted its holdings in shares of U.S. Physical Therapy by 6.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 3,381 shares of the company’s stock worth $253,000 after purchasing an additional 212 shares during the period.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc is a healthcare company that operates outpatient physical therapy clinics and manages physical therapy practices throughout the United States. Its clinics provide rehabilitation services for patients recovering from injuries, surgeries, illnesses and chronic conditions, with treatment commonly focused on restoring mobility, strength and function.

The company operates both physical therapy facilities and physical therapy management partnerships. In addition to traditional outpatient rehabilitation, its services include sports medicine, workers’ compensation care and related programs designed to help employers prevent and manage workplace injuries.